Alpha Teknova, Inc. (TKNO) Stock Grade

About Alpha Teknova, Inc.'s fundamentals

Alpha Teknova is a specialty and generic drug manufacturer with a market capitalization of $203.2 million that generated revenue growth of 7.4% year-over-year, indicating modest top-line expansion. However, the company operates at a significant loss, with a net margin of -42.6%, meaning it spent $0.43 for every dollar of revenue, resulting in a net loss for its latest annual period. The company does not pay a dividend, and traditional profitability metrics like P/E ratio and return on equity are not applicable given the loss position.